We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study Evaluating the Safety and Efficacy of the LentiGlobin® BB305 Drug Product in Beta-Thalassemia Major Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01745120
Recruitment Status : Active, not recruiting
First Posted : December 7, 2012
Last Update Posted : December 18, 2017
Information provided by (Responsible Party):
bluebird bio

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : March 2018
  Study Completion Date : No date given